The overall aim of the Joint Programming is to pool national research efforts, by the efficient use of Europe's public R&D funds, and by tackling common European grand societal challenges, which are beneficial for society and European competitiveness. This aim is shared with the Member States’ common vision for strategic research agendas on addressing those major societal challenges.
Joint Technology Initiatives evolved out of a limited number of European Technology Platforms (ETPs) that bring together industry and other stakeholders on specific topics to define research priorities. JTIs are a means to implement the Strategic Research Agendas (SRAs) of some of these European Technology Platforms.
European Partnerships bring the European Commission and private and/or public partners together to address some of Europe’s most pressing challenges through concerted research and innovation initiatives. They are a key implementation tool of Horizon Europe, and contribute significantly to achieving the EU’s political priorities.
By bringing private and public partners together, European Partnerships help to avoid the duplication of investments and contribute to reducing the fragmentation of the research and innovation landscape in the EU.
Open call with SSH aspects in European Partnership for Personalised Medicine
The European Partnership for Personalised Medicine (EP PerMed) launched a transnational call with SSH aspects on Pharmacogenomic Strategies for Personalised Medicine with deadline for pre-proposals on 18 February 2025.
Open call with SSH aspects in European Partnership on transforming health and care systems (THCS)
The European Partnership on transforming health and care systems (THCS) launched the transnational call including SSH aspects "Better care closer to home: Enhancing primary and community care" with deadline for pre-proposals on 30 January 2025.
Open call with SSH aspects in ERA4Health
ERA4Health launched a transnational call with SSH aspects on Fostering Pragmatic Comparative-Effectiveness Trials in Noncommunicable Diseases (EffecTrial) with pre-proposal deadline on 28 January 2025.